{
  "metadata": {
    "test_time": "20250502_112303",
    "num_questions": 5,
    "model": "deepseek-chat"
  },
  "results": [
    {
      "question": "What are the early symptoms of diabetes mellitus?",
      "expected": "Early symptoms of diabetes mellitus include polydipsia (excessive thirst), polyphagia (excessive hunger), polyuria (excessive urination), and blurred vision.",
      "basic_prompt": "What are the early symptoms of diabetes mellitus?",
      "basic_response": "The early symptoms of diabetes mellitus (both **Type 1** and **Type 2**) can be subtle and develop gradually. Recognizing them early can help in timely diagnosis and management. Here are the most common early signs:\n\n### **Common Early Symptoms of Diabetes:**\n1. **Increased Thirst (Polydipsia)** â€“ Excessive thirst due to high blood sugar levels.\n2. **Frequent Urination (Polyuria)** â€“ The kidneys try to remove excess glucose through urine, leading to more bathroom trips.\n3. **Extreme Hunger (Polyphagia)** â€“ Despite eating, cells donâ€™t get enough glucose, causing persistent hunger.\n4. **Unexplained Weight Loss** â€“ Common in **Type 1 diabetes**, as the body breaks down muscle and fat for energy when insulin is lacking.\n5. **Fatigue & Weakness** â€“ Due to poor glucose uptake by cells, leading to low energy.\n6. **Blurred Vision** â€“ High blood sugar can cause swelling in the eye lens, affecting focus.\n7. **Slow-Healing Wounds or Frequent Infections** â€“ High glucose impairs circulation and immune function.\n8. **Tingling or Numbness in Hands/Feet (Neuropathy)** â€“ Early nerve damage from prolonged high blood sugar.\n9. **Dry Skin & Itching** â€“ Dehydration and poor circulation can cause skin issues.\n10. **Recurrent Yeast Infections (Thrush)** â€“ High sugar levels promote fungal growth.\n\n### **Differences Between Type 1 & Type 2 Diabetes:**\n- **Type 1 Diabetes** often has **rapid onset** (weeks/months) with more severe symptoms like weight loss and ketoacidosis (fruity-smelling breath, nausea, vomiting).\n- **Type 2 Diabetes** develops **slowly** (years), and some people may have **no symptoms** initially (detected via routine blood tests).\n\n### **When to See a Doctor?**\nIf you experience these symptoms, especially if you have risk factors (family history, obesity, sedentary lifestyle, high blood pressure), consult a healthcare provider for testing (**fasting blood sugar, HbA1c, or oral glucose tolerance test**).\n\nEarly detection and lifestyle changes (diet, exercise, medication) can prevent complications like heart disease, kidney damage, and neuropathy.",
      "expert_prompt": "ä½ æ˜¯ä¸€åç³–å°¿ç—…ä¸“ç§‘åŒ»ç”Ÿï¼Œè¯·ç”¨ä¸“ä¸šåŒ»å­¦çŸ¥è¯†å›ç­”ä»¥ä¸‹é—®é¢˜ã€‚è¦æ±‚ï¼š\n1. ä½¿ç”¨æ ‡å‡†åŒ»å­¦æœ¯è¯­ï¼ˆå¦‚\"å¤šé¥®ã€å¤šå°¿ã€å¤šé£Ÿ\"ï¼‰\n2. åŒ…å«è¯Šæ–­æ ‡å‡†æ•°å€¼ï¼ˆå¦‚HbA1câ‰¥6.5%ï¼‰\n3. å¿…è¦æ—¶å¼•ç”¨æƒå¨æŒ‡å—\n\né—®é¢˜ï¼šWhat are the early symptoms of diabetes mellitus?",
      "expert_response": "ç³–å°¿ç—…æ—©æœŸç—‡çŠ¶ä¸»è¦ä¸é«˜è¡€ç³–ï¼ˆhyperglycemiaï¼‰åŠå…¶æ¸—é€æ€§åˆ©å°¿ã€ä»£è°¢ç´Šä¹±ä½œç”¨ç›¸å…³ï¼Œä»¥ä¸‹æ˜¯å…¸å‹ä¸´åºŠè¡¨ç°åŠè¯Šæ–­æ ‡å‡†ï¼š\n\n---\n\n### **ä¸€ã€å…¸å‹ç—‡çŠ¶ï¼ˆ\"ä¸‰å¤šä¸€å°‘\"ï¼‰**\n1. **å¤šå°¿ï¼ˆPolyuriaï¼‰**  \n   - è¡€ç³–è¶…è¿‡è‚¾ç³–é˜ˆï¼ˆé€šå¸¸â‰¥10 mmol/Lï¼‰å¯¼è‡´æ¸—é€æ€§åˆ©å°¿ï¼Œå°¿é‡å¢å¤šï¼ˆï¼2.5 L/å¤©ï¼‰ï¼Œå¤œå°¿é¢‘ç¹ã€‚\n\n2. **å¤šé¥®ï¼ˆPolydipsiaï¼‰**  \n   - å¤šå°¿å¼•å‘è„±æ°´ï¼Œåˆºæ¿€å£æ¸´ä¸­æ¢ï¼Œæ¯æ—¥é¥®æ°´é‡æ˜¾è‘—å¢åŠ ã€‚\n\n3. **å¤šé£Ÿï¼ˆPolyphagiaï¼‰**  \n   - èƒ°å²›ç´ ç¼ºä¹æˆ–æŠµæŠ—å¯¼è‡´è‘¡è„ç³–åˆ©ç”¨éšœç¢ï¼Œæœºä½“ä»£å¿æ€§é£Ÿæ¬²äº¢è¿›ï¼ˆå°¤å…¶1å‹ç³–å°¿ç—…ï¼‰ã€‚\n\n4. **ä½“é‡ä¸‹é™ï¼ˆWeight lossï¼‰**  \n   - å¤šè§äº1å‹ç³–å°¿ç—…æˆ–ä¸¥é‡2å‹ç³–å°¿ç—…ï¼Œå› è„‚è‚ª/è›‹ç™½è´¨åˆ†è§£ä»£è°¢å¢åŠ ï¼ˆå°½ç®¡å¤šé£Ÿï¼‰ã€‚\n\n---\n\n### **äºŒã€éç‰¹å¼‚æ€§ç—‡çŠ¶**\n- **ç–²ä¹æ— åŠ›**ï¼šç»†èƒèƒ½é‡åˆ©ç”¨éšœç¢ï¼ˆATPç”Ÿæˆå‡å°‘ï¼‰ã€‚  \n- **çš®è‚¤ç˜™ç—’**ï¼šé«˜è¡€ç³–å¯¼è‡´çš®è‚¤å¹²ç‡¥æˆ–å±€éƒ¨çœŸèŒæ„ŸæŸ“ï¼ˆå¦‚å¤–é˜´ç˜™ç—’ï¼‰ã€‚  \n- **è§†åŠ›æ¨¡ç³Š**ï¼šæ™¶çŠ¶ä½“æ¸—é€å‹æ”¹å˜å¼•èµ·çš„æš‚æ—¶æ€§å±ˆå…‰å¼‚å¸¸ã€‚  \n- **ä¼¤å£æ„ˆåˆå»¶è¿Ÿ**ï¼šé«˜è¡€ç³–æŸå®³å¾®å¾ªç¯åŠå…ç–«åŠŸèƒ½ã€‚  \n- **åå¤æ„ŸæŸ“**ï¼šå¦‚æ³Œå°¿ç³»æ„ŸæŸ“ã€çš®è‚¤ç––è‚¿ï¼ˆè‘¡è„ç³–ä½œä¸ºå¾®ç”Ÿç‰©åŸ¹å…»åŸºï¼‰ã€‚\n\n---\n\n### **ä¸‰ã€è¯Šæ–­æ ‡å‡†ï¼ˆä¾æ®ADA 2023æŒ‡å—ï¼‰**\nç¬¦åˆä»¥ä¸‹ä»»ä¸€æ¡ä»¶å³å¯è¯Šæ–­ç³–å°¿ç—…ï¼š  \n1. **ç©ºè…¹è¡€ç³–ï¼ˆFPGï¼‰â‰¥7.0 mmol/L**ï¼ˆâ‰¥126 mg/dLï¼‰  \n2. **OGTT 2å°æ—¶è¡€ç³–â‰¥11.1 mmol/L**ï¼ˆâ‰¥200 mg/dLï¼‰  \n3. **HbA1câ‰¥6.5%**ï¼ˆæ ‡å‡†åŒ–æ£€æµ‹ï¼‰  \n4. **éšæœºè¡€ç³–â‰¥11.1 mmol/L**ä¼´å…¸å‹ç—‡çŠ¶  \n\n---\n\n### **å››ã€ç‰¹æ®Šæ³¨æ„äº‹é¡¹**\n- **æ— ç—‡çŠ¶æ‚£è€…**ï¼šéœ€é‡å¤æ£€æµ‹ç¡®è®¤ï¼ˆå¦‚HbA1cä¸¤æ¬¡â‰¥6.5%ï¼‰ã€‚  \n- **å„¿ç«¥/é’å°‘å¹´**ï¼šå¯èƒ½ä»¥é…®ç—‡é…¸ä¸­æ¯’ï¼ˆDKAï¼‰èµ·ç—…ï¼ˆå‘•åã€è…¹ç—›ã€å‘¼å¸æ·±å¿«ï¼‰ã€‚  \n- **å¦Šå¨ ç³–å°¿ç—…**ï¼šéœ€é€šè¿‡75g OGTTç­›æŸ¥ï¼ˆç©ºè…¹â‰¥5.1 mmol/Læˆ–1å°æ—¶â‰¥10.0 mmol/Læˆ–2å°æ—¶â‰¥8.5 mmol/Lï¼‰ã€‚  \n\n---\n\n### **æƒå¨å¼•ç”¨**\n- **ç¾å›½ç³–å°¿ç—…åä¼šï¼ˆADAï¼‰**ï¼šã€ŠStandards of Medical Care in Diabetesâ€”2023ã€‹  \n- **WHO**ï¼šã€ŠClassification and Diagnosis of Diabetes Mellitus, 2019ã€‹  \n\næ—©æœŸè¯†åˆ«ç—‡çŠ¶å¹¶æ£€æµ‹è¡€ç³–è‡³å…³é‡è¦ï¼Œå¯é¿å…æ€¥æ€§å¹¶å‘ç—‡ï¼ˆå¦‚DKAï¼‰åŠæ…¢æ€§å¾®è¡€ç®¡ç—…å˜ã€‚",
      "patient_prompt": "è¯·ç”¨é€šä¿—æ˜“æ‡‚çš„è¯­è¨€å‘ç³–å°¿ç—…æ‚£è€…è§£é‡Šï¼š\né—®é¢˜ï¼šWhat are the early symptoms of diabetes mellitus?\nè¦æ±‚ï¼š\n1. é¿å…å¤æ‚åŒ»å­¦æœ¯è¯­\n2. ç»™å‡ºå®ç”¨å»ºè®®\n3. ä¿æŒæ¸©æš–å‹å¥½çš„è¯­æ°”",
      "patient_response": "å½“ç„¶ï¼ç³–å°¿ç—…æ—©æœŸå¯èƒ½ä¼šæ‚„æ‚„å‡ºç°ä¸€äº›â€œå°ä¿¡å·â€ï¼Œåˆ«æ‹…å¿ƒï¼Œæˆ‘æ¥å¸®ä½ ç”¨ç®€å•çš„è¯è§£é‡Šï¼Œå¹¶å‘Šè¯‰ä½ è¯¥æ€ä¹ˆåšï¼š\n\n**1. æ€»æ˜¯å£æ¸´ã€è€è·‘å•æ‰€**  \nå°±åƒèº«ä½“é‡Œçš„ç³–åˆ†å¤šäº†ï¼Œä¼šåƒâ€œå°æµ·ç»µâ€ä¸€æ ·å¸èµ°æ°´åˆ†ï¼Œè®©ä½ å£å¹²æƒ³å–æ°´ï¼Œå–å¤šäº†è‡ªç„¶å°¿ä¹Ÿå¤šï¼ˆå°¤å…¶æ˜¯æ™šä¸Šé¢‘ç¹èµ·å¤œï¼‰ã€‚\n\n**2. å®¹æ˜“é¥¿å´ç˜¦äº†**  \nåƒå¾—å¤šåè€Œä½“é‡æ‰ï¼Ÿå› ä¸ºèº«ä½“æ²¡æ³•å¥½å¥½ç”¨ç³–åˆ†å½“èƒ½é‡ï¼Œåªå¥½â€œçƒ§â€è„‚è‚ªï¼Œå°±åƒå­˜æ¬¾å–ä¸å‡ºé’±ï¼Œåªèƒ½èŠ±è€æœ¬ã€‚\n\n**3. ç´¯å¾—åƒæ‰‹æœºæ²¡ç”µ**  \nç³–åˆ†è¿›ä¸äº†ç»†èƒï¼Œäººå°±ä¼šæ²¡åŠ²å„¿ï¼Œæ˜æ˜æ²¡å¹²å•¥å´æ€»è§‰å¾—ç–²åŠ³ï¼Œåˆç¡åè¿˜æ˜¯æ˜æ˜æ²‰æ²‰ã€‚\n\n**4. ä¼¤å£å¥½å¾—æ…¢**  \nå°ä¼¤å£æˆ–ç‰™é¾ˆçº¢è‚¿è¿Ÿè¿Ÿä¸æ„ˆåˆï¼Œå¯èƒ½æ˜¯é«˜è¡€ç³–å½±å“äº†ä¿®å¤èƒ½åŠ›ï¼Œåƒæµ‡èŠ±çš„æ°´é‡Œæ··äº†ç³–ï¼Œåè€Œä¸åˆ©äºæ¤ç‰©ç”Ÿé•¿ã€‚\n\n**5. æ‰‹è„šå‘éº»/çœ‹ä¸œè¥¿æ¨¡ç³Š**  \nè¡€ç³–é«˜ä¼šâ€œæ³¡â€ç€ç¥ç»å’Œè¡€ç®¡ï¼Œåƒç”µçº¿å—æ½®æ¥è§¦ä¸è‰¯ï¼Œå¯èƒ½æ‰‹è„šåˆºç—›ï¼Œæˆ–çœ¼ç›åƒè’™äº†å±‚é›¾ã€‚\n\n**âœ¨ å®ç”¨å°å»ºè®®ï¼š**  \nâ€¢ **åˆ«çŠ¹è±«ï¼Œæµ‹è¡€ç³–ï¼** è¯åº—æœ‰å®¶ç”¨è¡€ç³–ä»ªï¼Œç©ºè…¹â‰¥7æˆ–é¤åâ‰¥11è¦è­¦æƒ•ã€‚  \nâ€¢ **å…ˆæˆ’ç”œé¥®å°é›¶é£Ÿ**ï¼šæŠŠå¯ä¹æ¢æˆç™½æ°´ï¼Œé¥¿çš„æ—¶å€™åƒé»„ç“œæˆ–åšæœã€‚  \nâ€¢ **åŠ¨èµ·æ¥å¾ˆç®€å•**ï¼šæ¯å¤©æ•£æ­¥20åˆ†é’Ÿï¼Œæ¯”åç€åˆ·æ‰‹æœºæ›´èƒ½å¸®è¡€ç³–â€œå¾€ä¸‹èµ°â€ã€‚  \nâ€¢ **è®°å½•èº«ä½“å˜åŒ–**ï¼šå†™ä¸ªç—‡çŠ¶å°æ—¥è®°ï¼ˆæ¯”å¦‚å“ªå¤©ç‰¹åˆ«æ¸´ã€å°¿å‡ æ¬¡ï¼‰ï¼Œçœ‹åŒ»ç”Ÿæ—¶æ›´æ¸…æ¥šã€‚  \n\nåˆ«è¢«è¿™äº›ä¿¡å·å“åˆ°ï¼Œæ—©æœŸå‘ç°æ˜¯å¥½äº‹ï¼å°±åƒæ±½è½¦äº®æ•…éšœç¯ï¼ŒåŠæ—¶æ£€æŸ¥å°±èƒ½é¿å…å¤§é—®é¢˜ã€‚æ˜å¤©å°±å¯ä»¥ä»å°‘å–ä¸€ç“¶ç”œé¥®æ–™å¼€å§‹æ”¹å˜å•¦~ ğŸ’ª  \n\nï¼ˆå¦‚æœå·²ç»æœ‰è¿™äº›ç—‡çŠ¶ï¼Œè®°å¾—çº¦åŒ»ç”ŸèŠèŠå¤©ï¼Œæ£€æŸ¥å°±åƒç»™èº«ä½“åšä¸ªå¹´åº¦ä¿å…»ï¼Œä¸ç–¼çš„ï¼ï¼‰"
    },
    {
      "question": "How is diabetes mellitus diagnosed?",
      "expected": "Diabetes mellitus is diagnosed by measuring plasma glucose levels.",
      "basic_prompt": "How is diabetes mellitus diagnosed?",
      "basic_response": "Diabetes mellitus is diagnosed through a combination of clinical evaluation and laboratory tests. The key diagnostic criteria, as outlined by organizations like the **American Diabetes Association (ADA)** and the **World Health Organization (WHO)**, include:\n\n### **1. Blood Glucose Tests**  \n   - **Fasting Plasma Glucose (FPG):**  \n     - **Diabetes:** â‰¥ **126 mg/dL (7.0 mmol/L)** (after an 8-hour fast)  \n     - **Prediabetes:** **100â€“125 mg/dL (5.6â€“6.9 mmol/L)**  \n   - **Random Plasma Glucose:**  \n     - **Diabetes:** â‰¥ **200 mg/dL (11.1 mmol/L)** with classic symptoms (e.g., excessive thirst, frequent urination, unexplained weight loss)  \n\n### **2. Oral Glucose Tolerance Test (OGTT)**  \n   - Measures blood glucose **2 hours** after consuming **75g of glucose**  \n   - **Diabetes:** â‰¥ **200 mg/dL (11.1 mmol/L)**  \n   - **Prediabetes (Impaired Glucose Tolerance):** **140â€“199 mg/dL (7.8â€“11.0 mmol/L)**  \n\n### **3. Hemoglobin A1c (HbA1c) Test**  \n   - Reflects **average blood glucose over 2â€“3 months**  \n   - **Diabetes:** â‰¥ **6.5% (48 mmol/mol)**  \n   - **Prediabetes:** **5.7â€“6.4% (39â€“47 mmol/mol)**  \n\n### **4. Additional Testing (if needed)**  \n   - **Autoantibody testing** (for **Type 1 diabetes**)  \n   - **C-peptide levels** (to assess insulin production)  \n\n### **Diagnosis Confirmation**  \n- **At least two abnormal test results** (on separate days) are required unless symptoms are present with a single high glucose reading.  \n\nWould you like details on specific types of diabetes (Type 1 vs. Type 2) or further clarification on any test?",
      "expert_prompt": "ä½ æ˜¯ä¸€åç³–å°¿ç—…ä¸“ç§‘åŒ»ç”Ÿï¼Œè¯·ç”¨ä¸“ä¸šåŒ»å­¦çŸ¥è¯†å›ç­”ä»¥ä¸‹é—®é¢˜ã€‚è¦æ±‚ï¼š\n1. ä½¿ç”¨æ ‡å‡†åŒ»å­¦æœ¯è¯­ï¼ˆå¦‚\"å¤šé¥®ã€å¤šå°¿ã€å¤šé£Ÿ\"ï¼‰\n2. åŒ…å«è¯Šæ–­æ ‡å‡†æ•°å€¼ï¼ˆå¦‚HbA1câ‰¥6.5%ï¼‰\n3. å¿…è¦æ—¶å¼•ç”¨æƒå¨æŒ‡å—\n\né—®é¢˜ï¼šHow is diabetes mellitus diagnosed?",
      "expert_response": "ç³–å°¿ç—…ï¼ˆDiabetes Mellitus, DMï¼‰çš„è¯Šæ–­éœ€åŸºäºä¸´åºŠç—‡çŠ¶å’Œå®éªŒå®¤æ£€æŸ¥ç»“æœï¼Œç¬¦åˆä»¥ä¸‹ä»»æ„ä¸€æ¡æ ‡å‡†å³å¯ç¡®è¯Šï¼ˆä¾æ®**ç¾å›½ç³–å°¿ç—…åä¼šï¼ˆADAï¼‰2023æŒ‡å—**å’Œ**WHOæ ‡å‡†**ï¼‰ï¼š\n\n---\n\n### **1. å…¸å‹ç³–å°¿ç—…ç—‡çŠ¶ + å¼‚å¸¸è¡€ç³–å€¼**\n   - **ç—‡çŠ¶**ï¼šå¤šé¥®ï¼ˆpolydipsiaï¼‰ã€å¤šå°¿ï¼ˆpolyuriaï¼‰ã€ä½“é‡å‡è½»ï¼ˆunintentional weight lossï¼‰æˆ–ç³–å°¿ç—…é…®ç—‡é…¸ä¸­æ¯’ï¼ˆDKAï¼‰ç­‰æ€¥æ€§ä»£è°¢ç´Šä¹±è¡¨ç°ã€‚  \n   - **ä»»æ„æ—¶é—´è¡€ç³–**ï¼ˆéšæœºè¡€ç³–ï¼‰â‰¥ **11.1 mmol/L (200 mg/dL)**ã€‚\n\n---\n\n### **2. ç©ºè…¹è¡€ç³–ï¼ˆFPGï¼‰**\n   - **ç©ºè…¹ï¼ˆâ‰¥8å°æ—¶æœªè¿›é£Ÿï¼‰é™è„‰è¡€æµ†è¡€ç³–** â‰¥ **7.0 mmol/L (126 mg/dL)**ã€‚  \n   - *é‡å¤æ£€æµ‹ç¡®è®¤*ï¼ˆé™¤éç—‡çŠ¶æ˜ç¡®ä¸”è¡€ç³–æ˜¾è‘—å‡é«˜ï¼‰ã€‚\n\n---\n\n### **3. å£æœè‘¡è„ç³–è€é‡è¯•éªŒï¼ˆOGTTï¼‰**\n   - **75gæ— æ°´è‘¡è„ç³–è´Ÿè·å2å°æ—¶è¡€ç³–** â‰¥ **11.1 mmol/L (200 mg/dL)**ã€‚\n\n---\n\n### **4. ç³–åŒ–è¡€çº¢è›‹ç™½ï¼ˆHbA1cï¼‰**\n   - **HbA1c â‰¥ 6.5%**ï¼ˆéœ€é‡‡ç”¨NGSPè®¤è¯çš„æ ‡å‡†åŒ–æ£€æµ‹æ–¹æ³•ï¼‰ã€‚  \n   - *æ³¨æ„*ï¼šè´«è¡€ã€è¡€çº¢è›‹ç™½ç—…ã€å¦Šå¨ ç­‰æƒ…å†µä¸‹HbA1cå¯èƒ½ä¸å¯é ï¼Œéœ€æ”¹ç”¨å…¶ä»–æ ‡å‡†ã€‚\n\n---\n\n### **å…¶ä»–è¦ç‚¹**\n1. **æ— ç—‡çŠ¶æ‚£è€…**ï¼šéœ€è‡³å°‘ä¸¤æ¬¡å¼‚å¸¸æ£€æµ‹ç»“æœï¼ˆåŒä¸€æŒ‡æ ‡æˆ–ä¸åŒæŒ‡æ ‡ï¼‰ã€‚  \n2. **å¦Šå¨ ç³–å°¿ç—…ï¼ˆGDMï¼‰**ï¼šé‡‡ç”¨75g OGTTï¼Œæ»¡è¶³ä»»ä¸€è¡€ç³–å€¼å¼‚å¸¸ï¼ˆç©ºè…¹â‰¥5.1 mmol/Lï¼Œ1å°æ—¶â‰¥10.0 mmol/Lï¼Œ2å°æ—¶â‰¥8.5 mmol/Lï¼‰ã€‚  \n3. **ç³–å°¿ç—…å‰æœŸ**ï¼š  \n   - **ç©ºè…¹è¡€ç³–å—æŸï¼ˆIFGï¼‰**ï¼š6.1â€“6.9 mmol/Lï¼ˆWHOï¼‰æˆ–5.6â€“6.9 mmol/Lï¼ˆADAï¼‰ã€‚  \n   - **ç³–è€é‡å—æŸï¼ˆIGTï¼‰**ï¼šOGTT 2å°æ—¶è¡€ç³–7.8â€“11.0 mmol/Lã€‚  \n   - **HbA1c 5.7â€“6.4%**ï¼ˆADAæ ‡å‡†ï¼‰ã€‚\n\n---\n\n### **æƒå¨æŒ‡å—ä¾æ®**\n- **ADA Standards of Medical Care in Diabetes (2023)**  \n- **WHO Classification and Diagnosis of Diabetes (2019)**\n\nè‹¥æœ‰ç–‘é—®æˆ–éœ€ä¸ªä½“åŒ–è¯„ä¼°ï¼Œå»ºè®®ç»“åˆæ‚£è€…ä¸´åºŠèƒŒæ™¯åŠå¹¶å‘ç—‡é£é™©ç»¼åˆåˆ¤æ–­ã€‚",
      "patient_prompt": "è¯·ç”¨é€šä¿—æ˜“æ‡‚çš„è¯­è¨€å‘ç³–å°¿ç—…æ‚£è€…è§£é‡Šï¼š\né—®é¢˜ï¼šHow is diabetes mellitus diagnosed?\nè¦æ±‚ï¼š\n1. é¿å…å¤æ‚åŒ»å­¦æœ¯è¯­\n2. ç»™å‡ºå®ç”¨å»ºè®®\n3. ä¿æŒæ¸©æš–å‹å¥½çš„è¯­æ°”",
      "patient_response": "å½“ç„¶ï¼ç³–å°¿ç—…çš„ç¡®è¯Šå…¶å®å¹¶ä¸å¤æ‚ï¼ŒåŒ»ç”Ÿä¸»è¦é€šè¿‡å‡ ä¸ªç®€å•çš„æ£€æŸ¥æ¥åˆ¤æ–­ã€‚ä¸‹é¢æˆ‘ç”¨æœ€æ˜“æ‡‚çš„æ–¹å¼ä¸ºä½ è§£é‡Šï¼Œå¹¶é™„ä¸Šä¸€äº›å®ç”¨å°å»ºè®®ï¼š\n\n---\n\n### **ç³–å°¿ç—…æ˜¯æ€ä¹ˆç¡®è¯Šçš„ï¼Ÿ**\n1. **éªŒè¡€æŸ¥è¡€ç³–**  \n   - **ç©ºè…¹è¡€ç³–**ï¼šæ—©ä¸Šèµ·åºŠåä¸åƒä¸å–ï¼ˆè‡³å°‘8å°æ—¶ï¼‰ï¼ŒæŠ½è¡€æµ‹è¡€ç³–ã€‚  \n     *æ­£å¸¸å€¼ï¼œ5.6 mmol/L* | *ç³–å°¿ç—…â‰¥7.0 mmol/L*  \n   - **éšæœºè¡€ç³–**ï¼šä»»ä½•æ—¶å€™æŠ½è¡€ï¼Œå¦‚æœè¡€ç³–ç‰¹åˆ«é«˜ï¼ˆâ‰¥11.1 mmol/Lï¼‰+ æœ‰å£æ¸´ã€å°¿å¤šç­‰ç—‡çŠ¶ï¼Œå¯èƒ½ç›´æ¥ç¡®è¯Šã€‚  \n\n2. **ç³–åŒ–è¡€çº¢è›‹ç™½ï¼ˆHbA1cï¼‰**  \n   - åæ˜ è¿‡å»2~3ä¸ªæœˆçš„å¹³å‡è¡€ç³–æ°´å¹³ï¼Œåƒâ€œè¡€ç³–æˆç»©å•â€ã€‚  \n   *æ­£å¸¸ï¼œ5.7%* | *ç³–å°¿ç—…â‰¥6.5%*  \n\n3. **å–ç³–æ°´æµ‹è¯•ï¼ˆOGTTï¼‰**  \n   - ç©ºè…¹å–ä¸€æ¯ç³–æ°´ï¼Œ2å°æ—¶åæµ‹è¡€ç³–ã€‚  \n   *æ­£å¸¸ï¼œ7.8 mmol/L* | *ç³–å°¿ç—…â‰¥11.1 mmol/L*  \n\n**æ³¨æ„**ï¼šä»¥ä¸Šæ£€æŸ¥ä¸€èˆ¬éœ€è¦é‡å¤ä¸€æ¬¡æˆ–ç»“åˆç—‡çŠ¶ç¡®è®¤ã€‚\n\n---\n\n### **ç»™ç³–å‹çš„å®ç”¨å»ºè®®**\n1. **æ£€æŸ¥å‰å‡†å¤‡**  \n   - ç©ºè…¹è¡€ç³–å‰ä¸€æ™š10ç‚¹ååˆ«åƒä¸œè¥¿ï¼ˆå¯ä»¥å–æ°´ï¼‰ã€‚  \n   - æ£€æŸ¥å‰é¿å…å‰§çƒˆè¿åŠ¨æˆ–ç†¬å¤œï¼Œè¿™äº›å¯èƒ½å½±å“ç»“æœã€‚  \n\n2. **å¦‚æœç¡®è¯Šäº†åˆ«æ…Œ**  \n   - ç³–å°¿ç—…å¯æ§ï¼é€šè¿‡é¥®é£Ÿã€è¿åŠ¨ã€è¯ç‰©ï¼ˆå¦‚éœ€ï¼‰é…åˆï¼Œå¾ˆå¤šäººæ´»å¾—å¥åº·é•¿å¯¿ã€‚  \n\n3. **æ—¥å¸¸ç›‘æµ‹**  \n   - å®¶é‡Œå¤‡ä¸ªè¡€ç³–ä»ªï¼Œå®šæœŸæµ‹ç©ºè…¹å’Œé¤åè¡€ç³–ï¼ˆåŒ»ç”Ÿä¼šå‘Šè¯‰ä½ é¢‘ç‡ï¼‰ã€‚  \n\n4. **æ—©æœŸä¿¡å·åˆ«å¿½è§†**  \n   - æ€»æ˜¯å£æ¸´ã€å°¿å¤šã€å®¹æ˜“é¥¿ã€ä½“é‡çªç„¶ä¸‹é™ã€ç–²åŠ³â€¦â€¦å»ºè®®å°½å¿«æ£€æŸ¥ã€‚  \n\n---\n\n### **æœ€åæƒ³å¯¹ä½ è¯´**  \nç³–å°¿ç—…å°±åƒèº«ä½“çš„â€œè¡€ç³–å°ç®¡å®¶â€æš‚æ—¶ç½¢å·¥äº†ï¼Œä½†æˆ‘ä»¬å¯ä»¥é€šè¿‡ç§‘å­¦æ–¹æ³•å¸®å®ƒæ¢å¤ç§©åºã€‚ç¡®è¯Šä¸æ˜¯ç»ˆç‚¹ï¼Œè€Œæ˜¯å¥åº·ç®¡ç†çš„èµ·ç‚¹ã€‚ä½ å¹¶ä¸å­¤å•ï¼ŒåŒ»ç”Ÿå’Œè¥å…»å¸ˆéƒ½ä¼šé™ªä½ ä¸€èµ·åˆ¶å®šè®¡åˆ’ã€‚è®°å¾—ï¼š**å°å°çš„æ”¹å˜ï¼Œä¼šå¸¦æ¥å¤§å¤§çš„ä¸åŒ** â¤ï¸  \n\nå¦‚æœæœ‰å…·ä½“ç–‘é—®ï¼Œéšæ—¶å’ŒåŒ»ç”Ÿæ²Ÿé€šï¼Œä»–ä»¬å¾ˆä¹æ„ä¸ºä½ è§£ç­”ï¼"
    },
    {
      "question": "What are the main treatment approaches for diabetes mellitus?",
      "expected": "Treatment for diabetes mellitus includes diet, exercise, and medications such as insulin, oral antihyperglycemic medications, and non-insulin injectable medications.",
      "basic_prompt": "What are the main treatment approaches for diabetes mellitus?",
      "basic_response": "Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia (high blood sugar) due to insulin deficiency, insulin resistance, or both. The main treatment approaches aim to maintain blood glucose levels within a target range, prevent complications, and improve quality of life. The strategies vary depending on the type of diabetes (Type 1, Type 2, or gestational diabetes) and individual patient factors.\n\n### **1. Lifestyle Modifications (Essential for All Types)**\n   - **Dietary Management:**  \n     - Carbohydrate counting, glycemic index awareness, and balanced meals (high fiber, lean proteins, healthy fats).  \n     - Limiting refined sugars and processed foods.  \n   - **Physical Activity:**  \n     - Regular aerobic exercise (e.g., walking, swimming) and resistance training improve insulin sensitivity.  \n   - **Weight Management:**  \n     - Particularly important for Type 2 diabetes and obesity-related insulin resistance.  \n\n### **2. Pharmacological Treatments**\n#### **For Type 1 Diabetes (Autoimmune Destruction of Pancreatic Beta Cells)**\n   - **Insulin Therapy (Mandatory):**  \n     - **Basal Insulin** (long-acting, e.g., glargine, detemir) for background glucose control.  \n     - **Bolus Insulin** (rapid-acting, e.g., lispro, aspart) for mealtime glucose spikes.  \n     - Insulin pumps or closed-loop systems (artificial pancreas) for precise delivery.  \n\n#### **For Type 2 Diabetes (Insulin Resistance + Progressive Beta-Cell Dysfunction)**\n   - **Oral Medications:**  \n     - **Metformin** (first-line, reduces hepatic glucose production).  \n     - **SGLT-2 Inhibitors** (e.g., empagliflozin, dapagliflozin) â€“ increase urinary glucose excretion.  \n     - **GLP-1 Receptor Agonists** (e.g., semaglutide, liraglutide) â€“ enhance insulin secretion, suppress glucagon, and promote satiety.  \n     - **DPP-4 Inhibitors** (e.g., sitagliptin) â€“ prolong incretin hormone action.  \n     - **Sulfonylureas** (e.g., glipizide) â€“ stimulate insulin secretion (risk of hypoglycemia).  \n     - **Thiazolidinediones** (e.g., pioglitazone) â€“ improve insulin sensitivity (caution in heart failure).  \n   - **Injectable Therapies:**  \n     - **GLP-1 RAs** (as above) and **insulin** (if oral agents fail).  \n\n#### **For Gestational Diabetes (Pregnancy-Induced Insulin Resistance)**\n   - **Diet & Exercise** (primary approach).  \n   - **Insulin** (if glucose targets are not met; preferred over oral agents due to safety).  \n   - **Metformin or Glyburide** (sometimes used off-label but less preferred).  \n\n### **3. Monitoring & Technology**\n   - **Self-Monitoring of Blood Glucose (SMBG):** Fingerstick testing.  \n   - **Continuous Glucose Monitoring (CGM):** Real-time tracking (e.g., Dexcom, Freestyle Libre).  \n   - **HbA1c Testing:** Every 3-6 months to assess long-term control (target usually <7%).  \n\n### **4. Emerging & Adjunctive Therapies**\n   - **Bariatric Surgery:** For obese Type 2 diabetes patients (can induce remission).  \n   - **Stem Cell & Islet Cell Transplantation:** Experimental for Type 1 diabetes.  \n   - **Artificial Pancreas Systems:** Automated insulin delivery.  \n\n### **5. Complication Prevention**\n   - **Cardiovascular Protection:** SGLT-2 inhibitors and GLP-1 RAs reduce heart disease risk.  \n   - **Blood Pressure & Lipid Control:** ACE inhibitors, statins.  \n   - **Foot & Eye Care:** Regular screenings for neuropathy and retinopathy.  \n\n### **Conclusion**\nTreatment is personalized based on diabetes type, severity, comorbidities, and patient preferences. While **Type 1 diabetes requires lifelong insulin**, **Type 2 diabetes** may be managed initially with lifestyle changes and oral medications, progressing to insulin if needed. **Gestational diabetes** focuses on maintaining safe glucose levels for mother and baby.  \n\nWould you like details on a specific treatment or type of diabetes?",
      "expert_prompt": "ä½ æ˜¯ä¸€åç³–å°¿ç—…ä¸“ç§‘åŒ»ç”Ÿï¼Œè¯·ç”¨ä¸“ä¸šåŒ»å­¦çŸ¥è¯†å›ç­”ä»¥ä¸‹é—®é¢˜ã€‚è¦æ±‚ï¼š\n1. ä½¿ç”¨æ ‡å‡†åŒ»å­¦æœ¯è¯­ï¼ˆå¦‚\"å¤šé¥®ã€å¤šå°¿ã€å¤šé£Ÿ\"ï¼‰\n2. åŒ…å«è¯Šæ–­æ ‡å‡†æ•°å€¼ï¼ˆå¦‚HbA1câ‰¥6.5%ï¼‰\n3. å¿…è¦æ—¶å¼•ç”¨æƒå¨æŒ‡å—\n\né—®é¢˜ï¼šWhat are the main treatment approaches for diabetes mellitus?",
      "expert_response": "ç³–å°¿ç—…ï¼ˆDiabetes Mellitus, DMï¼‰çš„æ²»ç–—éœ€åŸºäºåˆ†å‹ï¼ˆ1å‹ã€2å‹æˆ–å…¶ä»–ç‰¹æ®Šç±»å‹ï¼‰å’Œä¸ªä½“åŒ–åŸåˆ™ï¼Œä»¥ä¸‹æ˜¯ä¸»è¦æ²»ç–—ç­–ç•¥åŠä¾æ®ï¼š\n\n---\n\n### **ä¸€ã€ç”Ÿæ´»æ–¹å¼å¹²é¢„ï¼ˆæ‰€æœ‰ç±»å‹ç³–å°¿ç—…çš„åŸºç¡€æ²»ç–—ï¼‰**\n1. **åŒ»å­¦è¥å…»æ²»ç–—ï¼ˆMNTï¼‰**  \n   - ç›®æ ‡ï¼šæ§åˆ¶æ€»çƒ­é‡ï¼Œç»´æŒç†æƒ³ä½“é‡ï¼ˆBMI 18.5-24 kg/mÂ²ï¼‰ï¼Œç¢³æ°´åŒ–åˆç‰©å æ¯”45%-60%ï¼ˆä¼˜å…ˆä½å‡ç³–æŒ‡æ•°é£Ÿç‰©ï¼‰ã€‚  \n   - æƒå¨ä¾æ®ï¼š**ADAï¼ˆç¾å›½ç³–å°¿ç—…åä¼šï¼‰2023æŒ‡å—**å¼ºè°ƒä¸ªä½“åŒ–é¥®é£Ÿè®¡åˆ’ï¼Œæ¨èå‡å°‘ç²¾åˆ¶ç³–å’Œé¥±å’Œè„‚è‚ªï¼ˆï¼œ7%æ€»çƒ­é‡ï¼‰ã€‚\n\n2. **è¿åŠ¨ç–—æ³•**  \n   - å»ºè®®ï¼šæ¯å‘¨â‰¥150åˆ†é’Ÿä¸­ç­‰å¼ºåº¦æœ‰æ°§è¿åŠ¨ï¼ˆå¦‚å¿«èµ°ï¼‰ï¼Œç»“åˆæŠ—é˜»è®­ç»ƒï¼ˆæ¯å‘¨2-3æ¬¡ï¼‰ã€‚  \n   - æ³¨æ„ï¼š1å‹ç³–å°¿ç—…éœ€é¢„é˜²è¿åŠ¨åä½è¡€ç³–ï¼ˆè¡€ç³–ï¼œ3.9 mmol/Lï¼‰ã€‚\n\n---\n\n### **äºŒã€é™ç³–è¯ç‰©æ²»ç–—**\n#### **1. 2å‹ç³–å°¿ç—…ï¼ˆT2DMï¼‰**  \næ ¹æ®**ADA/EASD 2022å…±è¯†**ï¼Œè¯ç‰©é€‰æ‹©éœ€è€ƒè™‘åˆå¹¶ç—‡ï¼ˆå¦‚ASCVDã€å¿ƒè¡°ã€è‚¾ç—…ï¼‰ï¼š  \n- **ä¸€çº¿è¯ç‰©**ï¼š  \n  - **äºŒç”²åŒèƒ**ï¼šèµ·å§‹æ²»ç–—ï¼ˆé™¤éç¦å¿Œï¼‰ï¼ŒeGFRï¼œ30 mL/minæ—¶ç¦ç”¨ã€‚  \n  - **SGLT2æŠ‘åˆ¶å‰‚**ï¼ˆå¦‚æ©æ ¼åˆ—å‡€ï¼‰ï¼šåˆå¹¶ASCVDã€å¿ƒè¡°æˆ–æ…¢æ€§è‚¾ç—…ï¼ˆCKDï¼‰è€…ä¼˜å…ˆï¼Œå¯é™ä½å¿ƒè¡€ç®¡äº‹ä»¶åŠè‚¾ç—…è¿›å±•ï¼ˆeGFRâ‰¥20 mL/miné€‚ç”¨ï¼‰ã€‚  \n  - **GLP-1å—ä½“æ¿€åŠ¨å‰‚**ï¼ˆå¦‚å¸ç¾æ ¼é²è‚½ï¼‰ï¼šæ˜¾è‘—å‡é‡å¹¶é™ä½ASCVDé£é™©ï¼ˆHbA1cç›®æ ‡æœªè¾¾æ ‡æ—¶è”ç”¨ï¼‰ã€‚  \n\n- **å…¶ä»–é€‰æ‹©**ï¼š  \n  - DPP-4æŠ‘åˆ¶å‰‚ï¼ˆå¦‚è¥¿æ ¼åˆ—æ±€ï¼‰ã€èƒ°å²›ç´ ä¿ƒæ³Œå‰‚ï¼ˆå¦‚æ ¼åˆ—ç¾è„²ï¼‰ã€TZDsï¼ˆå¦‚å¡æ ¼åˆ—é…®ï¼‰ç­‰ï¼Œéœ€è­¦æƒ•ä½è¡€ç³–æˆ–å‰¯ä½œç”¨ï¼ˆå¦‚TZDså¢åŠ å¿ƒè¡°é£é™©ï¼‰ã€‚  \n\n#### **2. 1å‹ç³–å°¿ç—…ï¼ˆT1DMï¼‰**  \n- **èƒ°å²›ç´ æ›¿ä»£æ²»ç–—**ä¸ºæ ¸å¿ƒï¼š  \n  - **åŸºç¡€-é¤æ—¶æ–¹æ¡ˆ**ï¼šé•¿æ•ˆèƒ°å²›ç´ ï¼ˆå¦‚ç”˜ç²¾èƒ°å²›ç´ ï¼‰è”åˆé€Ÿæ•ˆèƒ°å²›ç´ ï¼ˆå¦‚é—¨å†¬èƒ°å²›ç´ ï¼‰ã€‚  \n  - **æŒç»­çš®ä¸‹èƒ°å²›ç´ è¾“æ³¨ï¼ˆCSIIï¼‰**ï¼šèƒ°å²›ç´ æ³µé€‚ç”¨äºè¡€ç³–æ³¢åŠ¨å¤§è€…ã€‚  \n- **è¾…åŠ©æ²»ç–—**ï¼š  \n  - æ™®å…°æ—è‚½ï¼ˆèƒ°æ·€ç´ ç±»ä¼¼ç‰©ï¼‰å¯å»¶ç¼“èƒƒæ’ç©ºï¼Œå‡å°‘é¤åè¡€ç³–æ³¢åŠ¨ã€‚  \n\n---\n\n### **ä¸‰ã€è¡€ç³–ç›‘æµ‹ä¸ç›®æ ‡**  \n- **ç›‘æµ‹æ–¹æ³•**ï¼šè‡ªæˆ‘è¡€ç³–ç›‘æµ‹ï¼ˆSMBGï¼‰ã€æŒç»­è‘¡è„ç³–ç›‘æµ‹ï¼ˆCGMï¼Œç›®æ ‡TIRï¼70%ï¼‰ã€‚  \n- **è¡€ç³–ç›®æ ‡**ï¼ˆADA 2023ï¼‰ï¼š  \n  - ç©ºè…¹/é¤å‰è¡€ç³–ï¼š4.4-7.2 mmol/L  \n  - é¤å2å°æ—¶è¡€ç³–ï¼šï¼œ10 mmol/L  \n  - HbA1cï¼šï¼œ7%ï¼ˆä¸ªä½“åŒ–è°ƒæ•´ï¼Œå¦‚è€å¹´æˆ–é«˜é£é™©æ‚£è€…å¯æ”¾å®½è‡³ï¼œ8%ï¼‰ã€‚  \n\n---\n\n### **å››ã€å¹¶å‘ç—‡ç®¡ç†**  \n1. **é«˜è¡€å‹**ï¼šç›®æ ‡ï¼œ130/80 mmHgï¼ˆACEI/ARBä¼˜å…ˆï¼Œå°¤å…¶åˆå¹¶è›‹ç™½å°¿ï¼‰ã€‚  \n2. **è¡€è„‚å¼‚å¸¸**ï¼šä»–æ±€ç±»ï¼ˆLDL-Cç›®æ ‡ï¼œ1.8 mmol/Lï¼‰ã€‚  \n3. **ç³–å°¿ç—…è‚¾ç—…**ï¼šSGLT2iæˆ–GLP-1RAå»¶ç¼“eGFRä¸‹é™ï¼ˆå°¿ç™½è›‹ç™½/è‚Œé…æ¯”â‰¥30 mg/gæ—¶å¯åŠ¨ï¼‰ã€‚  \n\n---\n\n### **äº”ã€ç‰¹æ®Šæƒ…å†µå¤„ç†**  \n- **å¦Šå¨ ç³–å°¿ç—…ï¼ˆGDMï¼‰**ï¼šèƒ°å²›ç´ ä¸ºé¦–é€‰ï¼ˆé—¨å†¬/åœ°ç‰¹èƒ°å²›ç´ ï¼‰ï¼Œç¦ç”¨å£æœé™ç³–è¯ï¼ˆé™¤äºŒç”²åŒèƒåœ¨æŸäº›æŒ‡å—ä¸­è°¨æ…ä½¿ç”¨ï¼‰ã€‚  \n- **é…®ç—‡é…¸ä¸­æ¯’ï¼ˆDKAï¼‰**ï¼šç´§æ€¥è¡¥æ¶²ã€èƒ°å²›ç´ é™æ»´ï¼ˆè¡€ç³–ä¸‹é™é€Ÿåº¦3-4 mmol/L/hï¼‰ï¼Œçº æ­£ç”µè§£è´¨ç´Šä¹±ã€‚  \n\n---\n\n### **æƒå¨æŒ‡å—å¼•ç”¨**  \n- **ADA Standards of Care in Diabetesâ€”2023**  \n- **EASD/ADA Consensus Report 2022**  \n- **ä¸­ååŒ»å­¦ä¼šç³–å°¿ç—…å­¦åˆ†ä¼šï¼ˆCDSï¼‰2021æŒ‡å—**  \n\næ²»ç–—éœ€åŠ¨æ€è¯„ä¼°ï¼Œç»“åˆæ‚£è€…ä»£è°¢çŠ¶æ€ã€å¹¶å‘ç—‡åŠç¤¾ä¼šå¿ƒç†å› ç´ è°ƒæ•´æ–¹æ¡ˆã€‚",
      "patient_prompt": "è¯·ç”¨é€šä¿—æ˜“æ‡‚çš„è¯­è¨€å‘ç³–å°¿ç—…æ‚£è€…è§£é‡Šï¼š\né—®é¢˜ï¼šWhat are the main treatment approaches for diabetes mellitus?\nè¦æ±‚ï¼š\n1. é¿å…å¤æ‚åŒ»å­¦æœ¯è¯­\n2. ç»™å‡ºå®ç”¨å»ºè®®\n3. ä¿æŒæ¸©æš–å‹å¥½çš„è¯­æ°”",
      "patient_response": "å½“ç„¶ï¼ç³–å°¿ç—…è™½ç„¶éœ€è¦é•¿æœŸç®¡ç†ï¼Œä½†é€šè¿‡ç§‘å­¦çš„æ–¹æ³•å®Œå…¨å¯ä»¥æ§åˆ¶å¥½ã€‚ä»¥ä¸‹æ˜¯ä¸»è¦çš„æ²»ç–—æ–¹æ³•å’Œå®ç”¨å»ºè®®ï¼Œç”¨ç®€å•çš„è¯è®²ç»™ä½ å¬ï¼š\n\n---\n\n### 1. **å¥åº·é¥®é£Ÿâ€”â€”\"åƒå¯¹é£Ÿç‰©\"**\n   - **å…³é”®ç‚¹**ï¼šé€‰æ‹©å‡ç³–æ…¢çš„é£Ÿç‰©ï¼Œæ§åˆ¶æ¯é¡¿é¥­çš„é‡ã€‚\n   - **æ€ä¹ˆåš**ï¼š\n     - å¤šåƒè”¬èœï¼ˆæ¯”å¦‚ç»¿å¶èœã€è¥¿å…°èŠ±ï¼‰ã€å…¨è°·ç‰©ï¼ˆç³™ç±³ã€ç‡•éº¦ï¼‰ã€ç˜¦è‚‰å’Œè±†ç±»ã€‚\n     - å°‘åƒç™½ç±³é¥­ã€ç™½é¢åŒ…ã€ç”œç‚¹ã€å«ç³–é¥®æ–™ï¼ˆå¦‚å¯ä¹ã€æœæ±ï¼‰ã€‚\n     - åƒé¥­æ—¶å…ˆåƒè”¬èœï¼Œå†åƒè›‹ç™½è´¨å’Œä¸»é£Ÿï¼Œèƒ½å¸®åŠ©è¡€ç³–æ›´å¹³ç¨³ã€‚\n   - **å°æŠ€å·§**ï¼šç”¨å°å·ç¢—ç›˜è£…é¥­ï¼Œé¿å…åƒå¤ªå¤šï¼›éšèº«å¸¦åšæœæˆ–æ— ç³–é…¸å¥¶å½“é›¶é£Ÿã€‚\n\n---\n\n### 2. **è§„å¾‹è¿åŠ¨â€”â€”\"åŠ¨èµ·æ¥\"**\n   - **å…³é”®ç‚¹**ï¼šè¿åŠ¨èƒ½å¸®èº«ä½“æ›´å¥½åœ°åˆ©ç”¨è¡€ç³–ã€‚\n   - **æ€ä¹ˆåš**ï¼š\n     - æ¯å‘¨è‡³å°‘5å¤©å¿«èµ°ã€è·³èˆæˆ–æ¸¸æ³³ï¼ˆæ¯æ¬¡30åˆ†é’Ÿå°±å¾ˆå¥½ï¼‰ã€‚\n     - ç®€å•æ—¥å¸¸æ´»åŠ¨ä¹Ÿæœ‰æ•ˆï¼Œæ¯”å¦‚å¤šèµ°è·¯ã€çˆ¬æ¥¼æ¢¯ã€‚\n   - **æ³¨æ„**ï¼šå¦‚æœè¡€ç³–å®¹æ˜“ä½ï¼Œè¿åŠ¨å‰æµ‹ä¸€ä¸‹è¡€ç³–ï¼Œéšèº«å¸¦é¢—ç³–ä»¥é˜²ä¸‡ä¸€ã€‚\n\n---\n\n### 3. **æŒ‰æ—¶ç”¨è¯â€”â€”\"å¬åŒ»ç”Ÿçš„è¯\"**\n   - **å…³é”®ç‚¹**ï¼šå¦‚æœéœ€è¦åƒè¯æˆ–æ‰“èƒ°å²›ç´ ï¼Œä¸€å®šè¦æŒ‰åŒ»ç”ŸæŒ‡å¯¼æ¥ã€‚\n   - **æ€ä¹ˆåš**ï¼š\n     - è®¾æ‰‹æœºæé†’ï¼Œé¿å…æ¼è¯ã€‚\n     - å¦‚æœæ‰“èƒ°å²›ç´ ï¼Œå­¦ä¼šè½®æ¢æ³¨å°„éƒ¨ä½ï¼ˆæ¯”å¦‚ä»Šå¤©æ‰“è‚šå­ï¼Œæ˜å¤©æ‰“å¤§è…¿ï¼‰ã€‚\n   - **åˆ«æ‹…å¿ƒ**ï¼šç”¨è¯æ˜¯ä¸ºäº†å¸®ä½ æ§åˆ¶è¡€ç³–ï¼Œå’Œåƒé¥­è¿åŠ¨ä¸€æ ·é‡è¦ã€‚\n\n---\n\n### 4. **ç›‘æµ‹è¡€ç³–â€”â€”\"å¿ƒé‡Œæœ‰æ•°\"**\n   - **å…³é”®ç‚¹**ï¼šå®šæœŸæµ‹è¡€ç³–å°±åƒçœ‹\"å¥åº·æˆç»©å•\"ã€‚\n   - **æ€ä¹ˆåš**ï¼š\n     - åŒ»ç”Ÿä¼šå‘Šè¯‰ä½ æµ‹çš„é¢‘ç‡ï¼ˆæ¯”å¦‚æ¯å¤©é¥­å‰æˆ–ç¡å‰ï¼‰ã€‚\n     - è®°å½•ç»“æœï¼Œä¸‹æ¬¡å°±è¯Šå¸¦ç»™åŒ»ç”Ÿçœ‹ã€‚\n   - **å°æé†’**ï¼šå¦‚æœè¡€ç³–ç»å¸¸åé«˜æˆ–åä½ï¼ŒåŠæ—¶è”ç³»åŒ»ç”Ÿè°ƒæ•´æ–¹æ¡ˆã€‚\n\n---\n\n### 5. **å¥½å¿ƒæ€å’Œå¥½ä¹ æƒ¯â€”â€”\"ç…§é¡¾è‡ªå·±\"**\n   - **å…³é”®ç‚¹**ï¼šå‹åŠ›å¤§æˆ–ç¡çœ å·®ä¼šè®©è¡€ç³–æ›´éš¾æ§åˆ¶ã€‚\n   - **æ€ä¹ˆåš**ï¼š\n     - æ¯å¤©ç¡å¤Ÿ7-8å°æ—¶ï¼Œç¡å‰å°‘ç©æ‰‹æœºã€‚\n     - æ‰¾å–œæ¬¢çš„äº‹æ”¾æ¾ï¼Œæ¯”å¦‚å¬éŸ³ä¹ã€æ•£æ­¥ã€å’Œæœ‹å‹èŠå¤©ã€‚\n     - æˆ’çƒŸé™é…’ï¼Œå®ƒä»¬ä¼šè®©è¡€ç³–æ³¢åŠ¨æ›´å¤§ã€‚\n\n---\n\n### æœ€åçš„å°é¼“åŠ±ï¼š\nç³–å°¿ç—…ç®¡ç†åƒ\"å¼€è½¦\"â€”â€”é¥®é£Ÿæ˜¯æ–¹å‘ç›˜ï¼Œè¿åŠ¨æ˜¯æ²¹é—¨ï¼Œè¯ç‰©æ˜¯å®‰å…¨å¸¦ï¼Œè¡€ç³–ç›‘æµ‹æ˜¯å¯¼èˆªã€‚å¶å°”èµ°é”™è·¯æ²¡å…³ç³»ï¼ŒåŠæ—¶è°ƒæ•´å°±å¥½ï¼ä½ å¹¶ä¸å­¤å•ï¼ŒåŒ»ç”Ÿå’Œå®¶äººéƒ½ä¼šé™ªä½ ä¸€èµ·ã€‚ğŸ’ª\n\nå¦‚æœæœ‰å…·ä½“é—®é¢˜ï¼ˆæ¯”å¦‚å¤–é£Ÿæ€ä¹ˆé€‰ã€è¿åŠ¨å¼ºåº¦ç­‰ï¼‰ï¼Œéšæ—¶é—®åŒ»ç”Ÿæˆ–è¥å…»å¸ˆå“¦ï¼"
    },
    {
      "question": "What are the two main categories of diabetes mellitus?",
      "expected": "The two main categories of diabetes mellitus are Type 1 and Type 2.",
      "basic_prompt": "What are the two main categories of diabetes mellitus?",
      "basic_response": "The two main categories of diabetes mellitus are:  \n\n1. **Type 1 Diabetes (T1D)** â€“ An autoimmune condition where the body's immune system attacks and destroys insulin-producing beta cells in the pancreas, leading to little or no insulin production. It typically develops in childhood or adolescence but can occur at any age. People with Type 1 diabetes require lifelong insulin therapy.  \n\n2. **Type 2 Diabetes (T2D)** â€“ A metabolic disorder characterized by insulin resistance (where the body doesnâ€™t use insulin effectively) and progressive insulin deficiency. It is more common in adults but is increasingly seen in younger individuals due to obesity and sedentary lifestyles. Management includes lifestyle changes, oral medications, and sometimes insulin.  \n\nOther forms include **gestational diabetes** (occurring during pregnancy) and **monogenic diabetes** (caused by a single gene mutation), but Type 1 and Type 2 are the most prevalent.",
      "expert_prompt": "ä½ æ˜¯ä¸€åç³–å°¿ç—…ä¸“ç§‘åŒ»ç”Ÿï¼Œè¯·ç”¨ä¸“ä¸šåŒ»å­¦çŸ¥è¯†å›ç­”ä»¥ä¸‹é—®é¢˜ã€‚è¦æ±‚ï¼š\n1. ä½¿ç”¨æ ‡å‡†åŒ»å­¦æœ¯è¯­ï¼ˆå¦‚\"å¤šé¥®ã€å¤šå°¿ã€å¤šé£Ÿ\"ï¼‰\n2. åŒ…å«è¯Šæ–­æ ‡å‡†æ•°å€¼ï¼ˆå¦‚HbA1câ‰¥6.5%ï¼‰\n3. å¿…è¦æ—¶å¼•ç”¨æƒå¨æŒ‡å—\n\né—®é¢˜ï¼šWhat are the two main categories of diabetes mellitus?",
      "expert_response": "ç³–å°¿ç—…ï¼ˆDiabetes Mellitus, DMï¼‰ä¸»è¦åˆ†ä¸ºä»¥ä¸‹ä¸¤å¤§ç±»ï¼Œä¾æ®ç—…å› ã€ç—…ç†ç”Ÿç†åŠä¸´åºŠç‰¹å¾è¿›è¡ŒåŒºåˆ†ï¼Œè¯Šæ–­æ ‡å‡†å‚è€ƒ**ç¾å›½ç³–å°¿ç—…åä¼šï¼ˆADAï¼‰æŒ‡å—**åŠ**WHOåˆ†ç±»**ï¼š\n\n---\n\n### **1. 1å‹ç³–å°¿ç—…ï¼ˆType 1 Diabetes Mellitus, T1DMï¼‰**  \n- **ç—…å› **ï¼šè‡ªèº«å…ç–«æ€§ï¼ˆå¤šæ•°ä¸ºèƒ°å²›Î²ç»†èƒç ´åå¯¼è‡´èƒ°å²›ç´ ç»å¯¹ç¼ºä¹ï¼‰ï¼Œæˆ–ç‰¹å‘æ€§ã€‚  \n- **ç‰¹å¾**ï¼š  \n  - å¸¸è§äºå„¿ç«¥/é’å°‘å¹´ï¼Œä½†å¯å‘ç”Ÿäºä»»ä½•å¹´é¾„ã€‚  \n  - èµ·ç—…æ€¥éª¤ï¼Œå…¸å‹ç—‡çŠ¶ä¸ºâ€œä¸‰å¤šä¸€å°‘â€ï¼ˆå¤šé¥®ã€å¤šå°¿ã€å¤šé£Ÿã€ä½“é‡ä¸‹é™ï¼‰ã€‚  \n  - æ˜“å‘ç”Ÿ**ç³–å°¿ç—…é…®ç—‡é…¸ä¸­æ¯’ï¼ˆDKAï¼‰**ã€‚  \n- **è¯Šæ–­æ ‡å‡†**ï¼š  \n  - éšæœºè¡€ç³–â‰¥11.1 mmol/Lï¼ˆ200 mg/dLï¼‰ä¼´ç—‡çŠ¶ï¼Œæˆ–  \n  - ç©ºè…¹è¡€ç³–ï¼ˆFPGï¼‰â‰¥7.0 mmol/Lï¼ˆ126 mg/dLï¼‰ï¼Œæˆ–  \n  - HbA1câ‰¥6.5%ï¼ˆéœ€æ’é™¤è¡€çº¢è›‹ç™½å˜å¼‚å¹²æ‰°ï¼‰ã€‚  \n  - è‡ªèº«æŠ—ä½“æ£€æµ‹ï¼ˆå¦‚GADAã€IA-2Aç­‰ï¼‰å¯è¾…åŠ©è¯Šæ–­ï¼ˆADA 2023æŒ‡å—æ¨èï¼‰ã€‚  \n\n---\n\n### **2. 2å‹ç³–å°¿ç—…ï¼ˆType 2 Diabetes Mellitus, T2DMï¼‰**  \n- **ç—…å› **ï¼šèƒ°å²›ç´ æŠµæŠ—ä¸ºä¸»ä¼´ç›¸å¯¹èƒ°å²›ç´ åˆ†æ³Œä¸è¶³ï¼Œæˆ–èƒ°å²›ç´ åˆ†æ³Œç¼ºé™·ä¸ºä¸»ä¼´èƒ°å²›ç´ æŠµæŠ—ã€‚  \n- **ç‰¹å¾**ï¼š  \n  - å¤šè§äºæˆäººï¼Œä½†è‚¥èƒ–é’å°‘å¹´å‘ç—…ç‡ä¸Šå‡ã€‚  \n  - èµ·ç—…éšåŒ¿ï¼Œæ—©æœŸå¯æ— ç—‡çŠ¶ï¼Œæˆ–ä»…è¡¨ç°ä¸ºç–²åŠ³ã€ä¼¤å£æ„ˆåˆå»¶è¿Ÿã€‚  \n  - å¸¸åˆå¹¶ä»£è°¢ç»¼åˆå¾ï¼ˆè‚¥èƒ–ã€é«˜è¡€å‹ã€è¡€è„‚å¼‚å¸¸ï¼‰ã€‚  \n- **è¯Šæ–­æ ‡å‡†**ï¼ˆåŒT1DMæ•°å€¼ï¼Œä½†éœ€ç»“åˆä¸´åºŠèƒŒæ™¯ï¼‰ï¼š  \n  - éœ€æ’é™¤å…¶ä»–ç±»å‹ç³–å°¿ç—…ï¼ˆå¦‚å•åŸºå› ç³–å°¿ç—…ã€ç»§å‘æ€§ç³–å°¿ç—…ï¼‰ã€‚  \n  - **ADAå¼ºè°ƒ**ï¼šHbA1câ‰¥6.5%éœ€åœ¨æ— æº¶è¡€ç­‰å› ç´ å¹²æ‰°ä¸‹é‡å¤ç¡®è®¤ã€‚  \n\n---\n\n### **å…¶ä»–é‡è¦åˆ†å‹ï¼ˆè¡¥å……è¯´æ˜ï¼‰**  \n- **å¦Šå¨ ç³–å°¿ç—…ï¼ˆGDMï¼‰**ï¼šå¦Šå¨ æœŸé—´é¦–æ¬¡å‘ç°çš„é«˜è¡€ç³–ï¼ˆéœ€é€šè¿‡75g OGTTè¯Šæ–­ï¼‰ã€‚  \n- **ç‰¹æ®Šç±»å‹ç³–å°¿ç—…**ï¼šå¦‚å•åŸºå› ç³–å°¿ç—…ï¼ˆå¦‚MODYï¼‰ã€èƒ°è…ºç–¾ç—…æˆ–è¯ç‰©ç»§å‘ç³–å°¿ç—…ã€‚  \n\n**æƒå¨å¼•ç”¨**ï¼š  \n- ADA Standards of Medical Care in Diabetes (2023)  \n- WHO Classification of Diabetes (2019)  \n\nä¸´åºŠå®è·µä¸­éœ€ç»“åˆæ‚£è€…ç—…å²ã€å®éªŒå®¤æ£€æŸ¥åŠå¹¶å‘ç—‡è¯„ä¼°è¿›è¡Œä¸ªä½“åŒ–åˆ†ç±»ä¸ç®¡ç†ã€‚",
      "patient_prompt": "è¯·ç”¨é€šä¿—æ˜“æ‡‚çš„è¯­è¨€å‘ç³–å°¿ç—…æ‚£è€…è§£é‡Šï¼š\né—®é¢˜ï¼šWhat are the two main categories of diabetes mellitus?\nè¦æ±‚ï¼š\n1. é¿å…å¤æ‚åŒ»å­¦æœ¯è¯­\n2. ç»™å‡ºå®ç”¨å»ºè®®\n3. ä¿æŒæ¸©æš–å‹å¥½çš„è¯­æ°”",
      "patient_response": "å½“ç„¶ï¼ç³–å°¿ç—…ä¸»è¦åˆ†ä¸ºä¸¤å¤§ç±»ï¼Œæˆ‘ä»¬å¯ä»¥ç”¨ç®€å•çš„æ–¹å¼æ¥ç†è§£å®ƒä»¬ï¼š\n\n### 1. **1å‹ç³–å°¿ç—…**  \n   - **é€šä¿—è§£é‡Š**ï¼šèº«ä½“é‡Œçš„â€œèƒ°å²›ç´ å·¥å‚â€ï¼ˆèƒ°è…ºï¼‰å®Œå…¨åœå·¥äº†ï¼Œè‡ªå·±ä¸€ç‚¹èƒ°å²›ç´ éƒ½ç”Ÿäº§ä¸å‡ºæ¥ã€‚å°±åƒæ‰‹æœºæ²¡äº†å……ç”µå™¨ï¼Œå¿…é¡»å¤–æ¥ç”µæºæ‰èƒ½ç”¨ã€‚  \n   - **å…³é”®ç‚¹**ï¼šé€šå¸¸æ˜¯å¹´è½»æ—¶å‘ç—…ï¼ˆä½†ä»»ä½•å¹´é¾„éƒ½å¯èƒ½ï¼‰ï¼Œå’Œè‡ªèº«å…ç–«æœ‰å…³ï¼ˆèº«ä½“è¯¯ä¼¤äº†èƒ°è…ºï¼‰ã€‚  \n   - **å®ç”¨å»ºè®®**ï¼š  \n     - å¿…é¡»æ¯å¤©æ³¨å°„èƒ°å²›ç´ ï¼Œå°±åƒåƒé¥­å–æ°´ä¸€æ ·é‡è¦ã€‚  \n     - éšèº«æºå¸¦ç³–æœæˆ–è‘¡è„ç³–ç‰‡ï¼Œé˜²æ­¢ä½è¡€ç³–ã€‚  \n     - å®šæœŸæµ‹è¡€ç³–ï¼Œå’ŒåŒ»ç”Ÿä¿æŒæ²Ÿé€šã€‚  \n\n### 2. **2å‹ç³–å°¿ç—…**  \n   - **é€šä¿—è§£é‡Š**ï¼šèº«ä½“çš„èƒ°å²›ç´ è¦ä¹ˆä¸å¤Ÿç”¨ï¼Œè¦ä¹ˆç”¨èµ·æ¥â€œä¸çµæ•â€ï¼ˆåƒé’¥åŒ™ç”Ÿé”ˆäº†ï¼Œæ‰“ä¸å¼€é—¨ï¼‰ã€‚å¤§éƒ¨åˆ†æ‚£è€…å±äºè¿™ä¸€ç±»å‹ã€‚  \n   - **å…³é”®ç‚¹**ï¼šå¸¸å’Œè‚¥èƒ–ã€å¹´é¾„ã€å®¶æ—å²æœ‰å…³ï¼Œæ—©æœŸå¯èƒ½é é¥®é£Ÿè¿åŠ¨æ§åˆ¶ï¼ŒåæœŸå¯èƒ½éœ€è¦è¯ç‰©æˆ–èƒ°å²›ç´ ã€‚  \n   - **å®ç”¨å»ºè®®**ï¼š  \n     - **é¥®é£Ÿ**ï¼šå°‘åƒç²¾åˆ¶ç³–å’Œæ²¹è…»é£Ÿç‰©ï¼Œå¤šåƒè”¬èœã€å…¨è°·ç‰©ã€‚  \n     - **è¿åŠ¨**ï¼šæ¯å¤©æ•£æ­¥30åˆ†é’Ÿå°±èƒ½å¸®è¡€ç³–â€œå¬è¯â€ã€‚  \n     - **ç›‘æµ‹**ï¼šå®šæœŸæŸ¥è¡€ç³–ï¼Œåˆ«ç­‰å£æ¸´ã€ä¹åŠ›æ‰é‡è§†ã€‚  \n\n### âœ¨ æ¸©æš–å°è´´å£«ï¼š  \næ— è®ºå“ªç§ç±»å‹ï¼Œç³–å°¿ç—…ç®¡ç†å°±åƒç…§é¡¾ä¸€ä½â€œæŒ‘å‰”çš„æœ‹å‹â€â€”â€”éœ€è¦è€å¿ƒå’Œè§„å¾‹ã€‚è¡€ç³–å¶å°”æ³¢åŠ¨åˆ«è‡ªè´£ï¼ŒåŠæ—¶è°ƒæ•´å°±å¥½ï¼è®°å¾—å®šæœŸæ‰¾åŒ»ç”Ÿâ€œå¯¹ç­”æ¡ˆâ€ï¼Œä½ å¹¶ä¸å­¤å•å“¦~  \n\nï¼ˆå¦‚æœéœ€è¦æ›´å…·ä½“çš„å»ºè®®ï¼Œæ¯”å¦‚é£Ÿè°±æˆ–è¿åŠ¨é€‰æ‹©ï¼Œéšæ—¶å‘Šè¯‰æˆ‘ï¼ï¼‰"
    },
    {
      "question": "What are some later complications of diabetes mellitus?",
      "expected": "Later complications of diabetes mellitus include vascular disease, peripheral neuropathy, nephropathy, and an increased predisposition to infection.",
      "basic_prompt": "What are some later complications of diabetes mellitus?",
      "basic_response": "Diabetes mellitus can lead to a variety of **long-term complications** if blood sugar levels are poorly controlled over time. These complications are broadly categorized into **microvascular** (small blood vessel damage) and **macrovascular** (large blood vessel damage) complications, along with other systemic effects.\n\n### **1. Microvascular Complications**  \n- **Diabetic Retinopathy** â€“ Damage to retinal blood vessels, leading to vision impairment or blindness.  \n- **Diabetic Nephropathy** â€“ Kidney damage, potentially progressing to **chronic kidney disease (CKD)** or **end-stage renal disease (ESRD)**.  \n- **Diabetic Neuropathy** â€“ Nerve damage, causing:  \n  - **Peripheral neuropathy** (numbness, pain, or ulcers in feet/hands).  \n  - **Autonomic neuropathy** (digestive issues, bladder dysfunction, erectile dysfunction, cardiovascular abnormalities).  \n\n### **2. Macrovascular Complications**  \n- **Cardiovascular Disease (CVD)** â€“ Increased risk of **coronary artery disease (CAD), heart attack, and stroke**.  \n- **Peripheral Artery Disease (PAD)** â€“ Reduced blood flow to limbs, increasing risk of **non-healing ulcers, infections, and amputations**.  \n\n### **3. Other Complications**  \n- **Diabetic Foot Ulcers & Infections** â€“ Due to poor circulation and neuropathy, leading to **gangrene** and possible **amputation**.  \n- **Skin Conditions** â€“ Increased susceptibility to bacterial/fungal infections (e.g., candidiasis).  \n- **Gastroparesis** â€“ Delayed stomach emptying due to autonomic neuropathy.  \n- **Increased Infection Risk** â€“ Poor wound healing and higher susceptibility to infections (e.g., UTIs, pneumonia).  \n- **Cognitive Decline** â€“ Some studies link diabetes to **dementia and Alzheimerâ€™s disease**.  \n- **Hearing Impairment** â€“ Higher prevalence of hearing loss in diabetics.  \n- **Bone & Joint Problems** â€“ Increased risk of **osteoporosis and Charcot joint (neuropathic arthropathy)**.  \n\n### **Prevention & Management**  \n- **Tight glycemic control** (HbA1c <7% for most patients).  \n- **Regular screenings** (eye exams, kidney function tests, foot checks).  \n- **Lifestyle modifications** (healthy diet, exercise, smoking cessation).  \n- **Blood pressure & cholesterol control** to reduce cardiovascular risks.  \n\nEarly detection and proper diabetes management can **delay or prevent** many of these complications.",
      "expert_prompt": "ä½ æ˜¯ä¸€åç³–å°¿ç—…ä¸“ç§‘åŒ»ç”Ÿï¼Œè¯·ç”¨ä¸“ä¸šåŒ»å­¦çŸ¥è¯†å›ç­”ä»¥ä¸‹é—®é¢˜ã€‚è¦æ±‚ï¼š\n1. ä½¿ç”¨æ ‡å‡†åŒ»å­¦æœ¯è¯­ï¼ˆå¦‚\"å¤šé¥®ã€å¤šå°¿ã€å¤šé£Ÿ\"ï¼‰\n2. åŒ…å«è¯Šæ–­æ ‡å‡†æ•°å€¼ï¼ˆå¦‚HbA1câ‰¥6.5%ï¼‰\n3. å¿…è¦æ—¶å¼•ç”¨æƒå¨æŒ‡å—\n\né—®é¢˜ï¼šWhat are some later complications of diabetes mellitus?",
      "expert_response": "ç³–å°¿ç—…æ…¢æ€§å¹¶å‘ç—‡å¯åˆ†ä¸º**å¾®è¡€ç®¡å¹¶å‘ç—‡**å’Œ**å¤§è¡€ç®¡å¹¶å‘ç—‡**ä¸¤å¤§ç±»ï¼Œä»¥ä¸‹ä¸ºåŸºäº**ç¾å›½ç³–å°¿ç—…åä¼šï¼ˆADAï¼‰2023æŒ‡å—**å’Œ**WHOæ ‡å‡†**çš„è¯¦ç»†æ€»ç»“ï¼š\n\n---\n\n### **ä¸€ã€å¾®è¡€ç®¡å¹¶å‘ç—‡**\n1. **ç³–å°¿ç—…è§†ç½‘è†œç—…å˜ï¼ˆDiabetic Retinopathy, DRï¼‰**  \n   - **ç—…ç†æœºåˆ¶**ï¼šé•¿æœŸé«˜è¡€ç³–ï¼ˆHbA1câ‰¥7.0%ï¼‰å¯¼è‡´è§†ç½‘è†œè¡€ç®¡é€šé€æ€§å¢åŠ ã€ç¼ºè¡€åŠæ–°ç”Ÿè¡€ç®¡å½¢æˆã€‚  \n   - **åˆ†æœŸ**ï¼š  \n     - éå¢æ®–æœŸï¼ˆNPDRï¼‰ï¼šå¾®åŠ¨è„‰ç˜¤ã€è§†ç½‘è†œå†…å‡ºè¡€ã€‚  \n     - å¢æ®–æœŸï¼ˆPDRï¼‰ï¼šæ–°ç”Ÿè¡€ç®¡ã€ç»ç’ƒä½“å‡ºè¡€ï¼Œå¯è‡´å¤±æ˜ã€‚  \n   - **ç­›æŸ¥**ï¼šç¡®è¯Š2å‹ç³–å°¿ç—…æˆ–1å‹ç³–å°¿ç—…ç—…ç¨‹â‰¥5å¹´è€…ï¼Œéœ€æ¯å¹´è¡Œçœ¼åº•æ£€æŸ¥ï¼ˆADAæ¨èï¼‰ã€‚\n\n2. **ç³–å°¿ç—…è‚¾ç—…ï¼ˆDiabetic Nephropathy, DNï¼‰**  \n   - **è¯Šæ–­æ ‡å‡†**ï¼š  \n     - æŒç»­æ€§ç™½è›‹ç™½å°¿ï¼ˆå°¿ç™½è›‹ç™½/è‚Œé…æ¯”å€¼â‰¥30 mg/gï¼‰  \n     - ä¼°ç®—è‚¾å°çƒæ»¤è¿‡ç‡ï¼ˆeGFRï¼‰<60 mL/min/1.73mÂ²  \n   - **ç»ˆæœ«æœŸé£é™©**ï¼šçº¦20-40%ç³–å°¿ç—…æ‚£è€…è¿›å±•è‡³ESRDï¼ˆéœ€é€ææˆ–ç§»æ¤ï¼‰ã€‚\n\n3. **ç³–å°¿ç—…å‘¨å›´ç¥ç»ç—…å˜ï¼ˆDPNï¼‰**  \n   - **è¡¨ç°**ï¼šå¯¹ç§°æ€§è¿œç«¯æ„Ÿè§‰å¼‚å¸¸ï¼ˆæ‰‹å¥—-è¢œå¥—æ ·åˆ†å¸ƒï¼‰ã€ç—›æ€§ç¥ç»ç—…å˜ã€è‡ªä¸»ç¥ç»ç—…å˜ï¼ˆå¦‚èƒƒè½»ç˜«ã€ç›´ç«‹æ€§ä½è¡€å‹ï¼‰ã€‚  \n   - **è¯Šæ–­**ï¼š10gå•å°¼é¾™ä¸è¯•éªŒ+ç¥ç»ä¼ å¯¼æ£€æŸ¥ï¼ˆADAå»ºè®®ç­›æŸ¥å§‹äºç¡®è¯Šæ—¶ï¼‰ã€‚\n\n---\n\n### **äºŒã€å¤§è¡€ç®¡å¹¶å‘ç—‡**\n1. **åŠ¨è„‰ç²¥æ ·ç¡¬åŒ–æ€§å¿ƒè¡€ç®¡ç–¾ç—…ï¼ˆASCVDï¼‰**  \n   - **é£é™©**ï¼šç³–å°¿ç—…æ‚£è€…å† å¿ƒç—…é£é™©å¢åŠ 2-4å€ï¼ˆLDL-Cç›®æ ‡<70 mg/dLï¼ŒADA 2023ï¼‰ã€‚  \n   - **è¡¨ç°**ï¼šå¿ƒè‚Œæ¢—æ­»ã€å’ä¸­ã€å¤–å‘¨åŠ¨è„‰ç–¾ç—…ï¼ˆå¦‚é—´æ­‡æ€§è·›è¡Œï¼‰ã€‚\n\n2. **ç³–å°¿ç—…è¶³ï¼ˆDiabetic Footï¼‰**  \n   - **æœºåˆ¶**ï¼šç¥ç»ç—…å˜+ç¼ºè¡€+æ„ŸæŸ“â†’æºƒç–¡/åç–½ã€‚  \n   - **æ•°æ®**ï¼šå…¨çƒ50%éåˆ›ä¼¤æ€§æˆªè‚¢ä¸ç³–å°¿ç—…ç›¸å…³ï¼ˆWHOï¼‰ã€‚  \n\n---\n\n### **ä¸‰ã€å…¶ä»–å¹¶å‘ç—‡**\n- **éª¨è´¨ç–æ¾**ï¼šé•¿æœŸé«˜è¡€ç³–æŠ‘åˆ¶æˆéª¨ç»†èƒæ´»æ€§ï¼ˆDXAæ‰«æTå€¼â‰¤-2.5ï¼‰ã€‚  \n- **è®¤çŸ¥åŠŸèƒ½éšœç¢**ï¼šç³–å°¿ç—…å¢åŠ é˜¿å°”èŒ¨æµ·é»˜ç—…é£é™©ï¼ˆHbA1cæ¯å‡é«˜1%ï¼Œé£é™©ä¸Šå‡15%ï¼‰ã€‚  \n\n---\n\n### **æƒå¨æŒ‡å—å¼•ç”¨**\n- **ADA 2023**ï¼šå¼ºè°ƒç»¼åˆç®¡ç†ï¼ˆè¡€å‹<130/80 mmHgï¼ŒSGLT-2i/GLP-1RAç”¨äºå¿ƒè‚¾ä¿æŠ¤ï¼‰ã€‚  \n- **KDIGO 2022**ï¼šç³–å°¿ç—…è‚¾ç—…æ‚£è€…æ¨èä½¿ç”¨SGLT-2æŠ‘åˆ¶å‰‚ï¼ˆeGFRâ‰¥20 mL/minï¼‰ã€‚  \n\næ—©æœŸè¡€ç³–æ§åˆ¶ï¼ˆHbA1c<7.0%ï¼‰å¯å»¶ç¼“å¹¶å‘ç—‡ï¼Œä½†éœ€ä¸ªä½“åŒ–ç›®æ ‡ï¼ˆå¦‚è€å¹´æ‚£è€…æ”¾å®½è‡³<8.0%ï¼‰ã€‚",
      "patient_prompt": "è¯·ç”¨é€šä¿—æ˜“æ‡‚çš„è¯­è¨€å‘ç³–å°¿ç—…æ‚£è€…è§£é‡Šï¼š\né—®é¢˜ï¼šWhat are some later complications of diabetes mellitus?\nè¦æ±‚ï¼š\n1. é¿å…å¤æ‚åŒ»å­¦æœ¯è¯­\n2. ç»™å‡ºå®ç”¨å»ºè®®\n3. ä¿æŒæ¸©æš–å‹å¥½çš„è¯­æ°”",
      "patient_response": "å½“ç„¶ï¼ç³–å°¿ç—…å¦‚æœæ§åˆ¶ä¸å¥½ï¼Œæ—¶é—´é•¿äº†å¯èƒ½ä¼šå¯¹èº«ä½“çš„å…¶ä»–éƒ¨åˆ†é€ æˆå½±å“ã€‚åˆ«æ‹…å¿ƒï¼Œåªè¦æˆ‘ä»¬å¹³æ—¶å¤šæ³¨æ„ï¼Œå°±èƒ½å¤§å¤§é™ä½è¿™äº›é£é™©ã€‚ä¸‹é¢æ˜¯ä¸€äº›å¯èƒ½çš„é—®é¢˜å’Œåº”å¯¹å»ºè®®ï¼Œç”¨ç®€å•çš„è¯è·Ÿä½ è¯´æ¸…æ¥šï¼š\n\n---\n\n### 1. **å¿ƒè„å’Œè¡€ç®¡é—®é¢˜**  \n   - **å¯èƒ½çš„å½±å“**ï¼šè¡€ç³–é«˜ä¹…äº†ï¼Œè¡€ç®¡å®¹æ˜“â€œç”Ÿé”ˆâ€ï¼ˆæ¯”å¦‚å˜ç¡¬æˆ–å µå¡ï¼‰ï¼Œå¯èƒ½å¼•å‘å¿ƒè„ç—…ã€ä¸­é£æˆ–è…¿è„šè¡€æ¶²å¾ªç¯å·®ï¼ˆèµ°è·¯è…¿ç–¼ã€ä¼¤å£éš¾æ„ˆåˆï¼‰ã€‚  \n   - **æ€ä¹ˆåŠ**ï¼š  \n     - å®šæœŸæµ‹è¡€å‹å’Œè¡€è„‚ï¼ˆå’Œè¡€ç³–ä¸€æ ·é‡è¦ï¼ï¼‰ã€‚  \n     - å¤šåƒè”¬èœã€å…¨è°·ç‰©ï¼Œå°‘åƒæ²¹è…»å’Œå’¸çš„é£Ÿç‰©ã€‚  \n     - æ¯å¤©æ•£æ­¥30åˆ†é’Ÿï¼Œç®€å•åˆæœ‰æ•ˆã€‚  \n\n### 2. **çœ¼ç›é—®é¢˜ï¼ˆç³–å°¿ç—…è§†ç½‘è†œç—…å˜ï¼‰**  \n   - **å¯èƒ½çš„å½±å“**ï¼šè¡€ç³–é«˜ä¼šä¼¤å®³çœ¼ç›çš„å°è¡€ç®¡ï¼Œå¯èƒ½è®©è§†åŠ›æ¨¡ç³Šï¼Œç”šè‡³å¤±æ˜ï¼ˆä½†è¿™æ˜¯é•¿æœŸä¸ç®¡æ‰ä¼šå‘ç”Ÿçš„ï¼ï¼‰ã€‚  \n   - **æ€ä¹ˆåŠ**ï¼š  \n     - æ¯å¹´æŸ¥ä¸€æ¬¡çœ¼åº•ï¼ˆåƒæ‹ç…§ä¸€æ ·ç®€å•ï¼‰ï¼Œæ—©å‘ç°æ—©æ²»ç–—ã€‚  \n     - æ§åˆ¶å¥½è¡€ç³–å’Œè¡€å‹ï¼Œèƒ½ä¿æŠ¤çœ¼ç›ã€‚  \n\n### 3. **è‚¾è„é—®é¢˜ï¼ˆç³–å°¿ç—…è‚¾ç—…ï¼‰**  \n   - **å¯èƒ½çš„å½±å“**ï¼šè‚¾è„åƒâ€œè¿‡æ»¤å™¨â€ï¼Œè¡€ç³–é«˜ä¼šè®©å®ƒç´¯åï¼Œä¸¥é‡æ—¶å¯èƒ½éœ€è¦é€æã€‚  \n   - **æ€ä¹ˆåŠ**ï¼š  \n     - å®šæœŸæŸ¥å°¿è›‹ç™½ï¼ˆå°ä¾¿æ£€æŸ¥ï¼‰ã€‚  \n     - å°‘åƒç›ï¼Œè¡€å‹é«˜çš„äººæ›´è¦æ³¨æ„ã€‚  \n\n### 4. **ç¥ç»æŸä¼¤ï¼ˆæ‰‹è„šå‘éº»ã€ç–¼ç—›ï¼‰**  \n   - **å¯èƒ½çš„å½±å“**ï¼šæ‰‹è„šåƒæˆ´äº†æ‰‹å¥—/è¢œå­ä¸€æ ·éº»æœ¨ï¼Œæˆ–åƒé’ˆæ‰ä¸€æ ·ç–¼ï¼Œä¸¥é‡æ—¶å¯èƒ½æ„Ÿè§‰ä¸åˆ°å—ä¼¤ï¼ˆæ¯”å¦‚çƒ«ä¼¤ï¼‰ã€‚  \n   - **æ€ä¹ˆåŠ**ï¼š  \n     - æ¯å¤©æ£€æŸ¥è„šéƒ¨ï¼Œç©¿æŸ”è½¯èˆ’é€‚çš„é‹å­ã€‚  \n     - æ³¡è„šå‰ç”¨æ‰‹è¯•æ°´æ¸©ï¼Œåˆ«çƒ«ä¼¤ã€‚  \n\n### 5. **æ„ŸæŸ“å’Œä¼¤å£éš¾æ„ˆåˆ**  \n   - **å¯èƒ½çš„å½±å“**ï¼šè¡€ç³–é«˜æ—¶ï¼Œèº«ä½“æŠ—ç—…èƒ½åŠ›å·®ï¼Œå°ä¼¤å£å¯èƒ½å˜å¤§é—®é¢˜ï¼ˆæ¯”å¦‚è„šéƒ¨æºƒç–¡ï¼‰ã€‚  \n   - **æ€ä¹ˆåŠ**ï¼š  \n     - ä¿æŒçš®è‚¤æ¸…æ´ï¼Œå°¤å…¶æ˜¯è„šéƒ¨ã€‚  \n     - å“ªæ€•å°ä¼¤å£ä¹Ÿè¦åŠæ—¶æ¶ˆæ¯’ï¼Œåˆ«æ‹–ç€ã€‚  \n\n### 6. **ç‰™é½¿å’Œç‰™é¾ˆé—®é¢˜**  \n   - **å¯èƒ½çš„å½±å“**ï¼šå®¹æ˜“ç‰™é¾ˆå‘ç‚ã€ç‰™é½¿æ¾åŠ¨ã€‚  \n   - **æ€ä¹ˆåŠ**ï¼š  \n     - æ¯å¤©åˆ·ç‰™ä¸¤æ¬¡ï¼Œç”¨è½¯æ¯›ç‰™åˆ·ã€‚  \n     - æ¯åŠå¹´æ´—ä¸€æ¬¡ç‰™ï¼Œå‘Šè¯‰ç‰™åŒ»ä½ æœ‰ç³–å°¿ç—…ã€‚  \n\n---\n\n### âœ¨ **å…³é”®æ€»ç»“**  \n- **æ§è¡€ç³–æ˜¯æ ¹æœ¬**ï¼šå°±åƒç®¡å¥½â€œç³–æ°´ç®¡â€åˆ«è®©å®ƒæ¼æ°´ï¼Œå…¶ä»–é—®é¢˜è‡ªç„¶å°‘ã€‚  \n- **å®šæœŸä½“æ£€**ï¼šæ¯å¹´æŸ¥çœ¼ç›ã€è‚¾è„ã€å¿ƒè„ï¼Œç›¸å½“äºç»™èº«ä½“â€œå¹´æ£€â€ã€‚  \n- **å°ä¹ æƒ¯å¤§ä½œç”¨**ï¼šå¥åº·é¥®é£Ÿã€å¤šæ´»åŠ¨ã€ä¸æŠ½çƒŸï¼Œè¿™äº›å°äº‹èƒ½é˜²ä½å¤§é—®é¢˜ï¼  \n\nåˆ«è¢«è¿™äº›å“åˆ°ï¼Œå…¶å®åªè¦æ¯å¤©å¤šæ³¨æ„ä¸€ç‚¹ï¼Œä½ å®Œå…¨èƒ½è¿‡å¾—å’Œå¥åº·äººä¸€æ ·å¥½ï¼å¦‚æœæœ‰å…·ä½“é—®é¢˜ï¼Œéšæ—¶æ‰¾åŒ»ç”ŸèŠï¼Œæˆ‘ä»¬ä¸€èµ·æƒ³åŠæ³•~ ğŸŒŸ  \n\nï¼ˆè§‰å¾—æœ‰ç”¨çš„è¯ï¼Œå¯ä»¥æ”¶è—èµ·æ¥æˆ–åˆ†äº«ç»™éœ€è¦çš„æœ‹å‹å“¦ï¼ï¼‰"
    }
  ]
}